We found that higher CD4 level was associated with longer overall survival (OS) (Fig. 2f, P < 0.05), while CD8 and tumor-infiltrating lymphocyte (TIL) scores approached statistical significance (Supplementary Fig. S2, P = 0.051 and 0.083, respectively). The gene discussed is CD4; the disease is neoplasm.